Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Autoantibodies neutralizing Type I interferons increase the risk of severe viral diseases and are linked to autoimmune conditions. The automated VIDAS assay is suitable for anti-IFN-α2 IgGs quantification, offering a swift, reliable, user-friendly, single test for clinical management.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11995241 | PMC |
| http://dx.doi.org/10.1002/eji.202451516 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
VIDAS® TB-IGRA assay for diagnosing tuberculosis infection in people living with HIV: A preliminary study.
Int J Infect Dis
September 2025
Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa; Faculty of Infectious and Tropical Diseases, Department of Immuno
Background: The diagnosis of presumed latent tuberculosis (TB) infection (LTBI) is problematic in people living with HIV (PLWH) because of sub-optimal sensitivity and high indeterminate rates, especially in those with advanced immunosuppression. Better diagnostic tools for LTBI are needed in this sub-population.
Methods: We compared the sensitivity of VIDAS TB-IGRA, a fully automated RD1-specific new interferon-ϒ-release assay (IGRA), to QFT-Plus in 77 PLWH with active pulmonary TB who had varying CD4 counts.
Preliminary performance of the VIDAS TB-IGRA as an aid in the diagnosis of individuals infected with .
J Clin Microbiol
June 2025
Public Health Research Institute, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
This preliminary study compares VIDAS TB-IGRA (bioMérieux, Marcy-l'Etoile, France) with the established QuantiFERON-TB Gold Plus (QFT-Plus) (Qiagen, Hilden, Germany) to evaluate diagnostic performance for the diagnosis of individuals infected with complex (latent infection and disease). The study was multi-center and performed between 2 October 2019 and 4 February 2020. Participants were divided into tuberculosis (TB) disease, high-risk, and low-risk populations.
View Article and Find Full Text PDFRapid Detection of Anti-IFN-α2 Autoantibodies Using a New Automated VIDAS Assay Prototype.
Eur J Immunol
April 2025
Joint Research Unit Civils Hospices of Lyon-bioMérieux, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
Autoantibodies neutralizing Type I interferons increase the risk of severe viral diseases and are linked to autoimmune conditions. The automated VIDAS assay is suitable for anti-IFN-α2 IgGs quantification, offering a swift, reliable, user-friendly, single test for clinical management.
View Article and Find Full Text PDFSeroconversion of SARS-CoV-2 Antibodies in Pregnant Women During the Second Wave of the COVID-19 Pandemic in India: A Longitudinal Study.
Cureus
November 2024
Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, IND.
Aim This study aims to investigate the seroconversion of antibodies against SARS-CoV-2 infection in pregnant women during their first and third trimesters, specifically during the second wave of the COVID-19 pandemic. Methodology This is a longitudinal follow-up study of pregnant women during the second peak of the COVID-19 pandemic. Patients in their first trimester (six to 12 weeks) were tested for SARS-CoV-2 IgM and IgG levels, with a repeat test conducted in the third trimester (28-40 weeks) using the automated VIDAS® (bioMérieux SA, Marcy-l'Étoile, France) system.
View Article and Find Full Text PDFLaboratory considerations in the assessment of 25-hydroxyvitamin D in pregnant women by automated immunoassays.
Pract Lab Med
November 2024
Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Background: Because of the pathophysiological role of vitamin D in health, there is an increased interest to check the clinical status of this vitamin. Immunochemical assays are commonly employed to determine 25-hydroxyvitamin D (25 (OH) D) in clinical laboratories and its testing could be influenced by pre-analytic and analytic issues. The aim of this study was to compare the 25(OH)D results obtained from three commonly used immunoassays in pregnant women to check a possible discrepancy between tests.
View Article and Find Full Text PDF